Compounds > 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide
Page last updated: 2024-11-05

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Infant, Premature, Diseases

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide has been researched along with Infant, Premature, Diseases in 1 studies

2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2H-tetrazolium hydroxide: structure given in first source

Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Seidler, M1
Salvenmoser, S1
Müller, FM1

Other Studies

1 other study available for 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide and Infant, Premature, Diseases

ArticleYear
In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
    International journal of antimicrobial agents, 2006, Volume: 28, Issue:6

    Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Biofilms; Candida; Candidiasis; Cat

2006